{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:41:31Z","timestamp":1793446891516,"version":"4.5.0"},"reference-count":61,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-PESN-0017"],"award-info":[{"award-number":["ANR-22-PESN-0017"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Dalbavancin is increasingly used off-label for prolonged therapy in gram-positive infections, but optimal repeat-dosing strategies remain undefined, and published population pharmacokinetic (popPK) models lack external validation in real-world cohorts. A popPK model was developed using routine therapeutic drug monitoring (TDM) data from 183 adults (406 concentrations) with gram-positive infections and externally validated in an independent cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 30, 92 concentrations). Predictive performance was benchmarked against five published models and a model averaging (MA) approach under three scenarios: a priori prediction and Bayesian forecasting with one or two TDM measurements. Monte Carlo simulations assessed the probability of target attainment (\n                      <jats:italic toggle=\"yes\">f<\/jats:italic>\n                      AUC\n                      <jats:sub>24<\/jats:sub>\n                      \/MIC \u2265111.1) for repeat-dose regimens (1,500 mg D1\/D8 and D1\/D15) at MICs 0.125 and 0.250 mg\/L. A two-compartment model with eGFR (clearance) and body weight (clearance and volumes) best described the data. In a priori external validation, it achieved the lowest rRMSE (49.8%) among published models. MA with two TDM measurements yielded optimal performance (rRMSE 26.9%), closely followed by our model (31.4%). Simulations showed that empirical regimens maintained target attainment of \u226590% for 3\u20137 weeks, heavily dependent on PD targets and patient characteristics. A third 1,500 mg dose, timed to target decline, restored prolonged coverage across all strata. This externally validated popPK model, complemented by MA, provides robust pharmacokinetic foundations for precision dosing in gram-positive infections requiring prolonged therapy. Based on these findings, we propose an investigational sequential precision dosing workflow integrating machine learning with Bayesian forecasting; prospective validation is required before clinical implementation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00665-26","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:00:44Z","timestamp":1782129644000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy"],"prefix":"10.1128","volume":"70","author":[{"given":"Hamza","family":"Sayadi","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]},{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-5761","authenticated-orcid":true,"given":"Matthieu","family":"Gregoire","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03gnr7b55","id-type":"ROR","asserted-by":"publisher"}],"name":"Clinical Pharmacology Department, Nantes University, Nantes University Hospital","place":["Nantes, France"]},{"id":[{"id":"https:\/\/ror.org\/03gnr7b55","id-type":"ROR","asserted-by":"publisher"}],"name":"Infection and Immunity: Targets and Drugs, IICiMed, UR 1155, Nantes University, Nantes University Hospital","place":["Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeleen","family":"Fromage","sequence":"additional","affiliation":[{"name":"INSERM CIC 1435, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Labriffe","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]},{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Maizaud","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Monchaud","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]},{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Codde","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]},{"name":"Department of Infectious and Tropical Diseases, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03gnr7b55","id-type":"ROR","asserted-by":"publisher"}],"name":"INSERM, Infectious and Tropical Diseases Department, CIC 1413, Nantes University, Nantes University Hospital","place":["Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]},{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":true,"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, Dupuytren University Hospital (CHU Dupuytren)","place":["Limoges, France"]},{"id":[{"id":"https:\/\/ror.org\/02cp04407","id-type":"ROR","asserted-by":"publisher"}],"name":"Pharmacology & Transplantation, INSERM U1248, University of Limoges","place":["Limoges, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122888"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki005"},{"key":"e_1_3_5_5_2","volume-title":"Dalvance (dalbavancin) for injection, for intravenous use [prescribing information]","author":"U.S. Food and Drug Administration","year":"2025","unstructured":"U.S. Food and Drug Administration. 2025 Dalvance (dalbavancin) for injection, for intravenous use [prescribing information]. Allergan USA, Inc., Madison, NJ."},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.04.007"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/497271"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310480"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ982"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1798227"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.07.018"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.04.046"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm263"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04550-14"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00274-15"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky235"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2021.1911518"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115195"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2122437"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106960"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105035"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.02.013"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-019-0329-6"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02280-18"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy331"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106749"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106918"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.12543"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01264-06"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01717-15"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106445"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106773"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.695"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02260-20"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14020190"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11080996"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13111103"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa188"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00937-4"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01233-7"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107038"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01363-25"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2025.2611431"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020480"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-021-00516-9"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12467"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12689"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2065"},{"key":"e_1_3_5_50_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2025. Breakpoint tables for interpretation of MICs and zone diameters. Available from: http:\/\/www.eucast.org"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094708"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.05.056"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01493-21"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky434"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.016"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2025.05.015"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01830-24"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-024-01410-2"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-022-04437-0"},{"key":"e_1_3_5_60_2","unstructured":"Shiny. 2024. Shiny. Available from: https:\/\/shiny.posit.co. Retrieved 25 Apr 2024."},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.2002.00442.x"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030515"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00665-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00665-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:01:34Z","timestamp":1785848494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00665-26"}},"subtitle":[],"editor":[{"given":"James E.","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,5]]}},"alternative-id":["10.1128\/aac.00665-26"],"URL":"https:\/\/doi.org\/10.1128\/aac.00665-26","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2026-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00665-26"}}